Find trials
Consejos para buscar

Long-term Safety Follow-up in Recipients Who Previously Received Medeor's Cellular Immunotherapy Products

Overview

Información sobre este estudio

The purpose of this study is to evaluate the long-term safety in patients previously treated with Medeor cellular immunotherapy products in a Medeor parent study.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

1. Able and willing to fully comply with all study procedures and restrictions.

2. Able to understand and provide written, signed, and dated informed consent to
participate in the study in accordance with ICH GCP Guideline and all applicable local
regulations.

3. Have previously completed a Medeor study and received a Medeor cellular immunotherapy
product

Exclusion Criteria:

1. Has any condition or circumstance, which in the opinion of the Investigator would
significantly interfere with the subject's protocol compliance or put the subject at
increased risk.

2. Unable or unwilling to provide written, signed, and dated informed consent to
participate in the study.

3. Has undergone a second organ transplant with an organ derived from an individual other
than the donor of the transplant kidney received during a Medeor study.

Eligibility last updated 8/8/22. Questions regarding updates should be directed to the study team contact.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Rochester, Minn.

Investigador principal de Mayo Clinic

Mark Stegall, M.D.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available

Otros temas en investigación

.
CLS-20540335

Mayo Clinic Footer